Cas:52783-66-1 3-Bromo-5-hydroxy-4-methoxybenzoic acid manufacturer & supplier

We serve Chemical Name:3-Bromo-5-hydroxy-4-methoxybenzoic acid CAS:52783-66-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Bromo-5-hydroxy-4-methoxybenzoic acid

Chemical Name:3-Bromo-5-hydroxy-4-methoxybenzoic acid
CAS.NO:52783-66-1
Synonyms:3-Bromo-5-hydroxy-4-methoxybenzoic;XKPMZMJYQDNWDG-UHFFFAOYSA;3-Bromo-5-hydroxy-4-methoxybenzoic acid;Benzoic acid, 3-bromo-5-hydroxy-4-methoxy-;Benzoic acid,3-bromo-5-hydroxy-4-methoxy;3-Bromo-5-hydroxy-4-methoxy benzoicacid
Molecular Formula:C8H7BrO4
Molecular Weight:247.043
HS Code:2918990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:380.5±42.0 °C at 760 mmHg
Density:1.8±0.1 g/cm3
Index of Refraction:1.621
PSA:66.76000
Exact Mass:245.952759
LogP:2.35

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-Bromo-5-hydroxy-4-methoxybenzoic chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Bromo-5-hydroxy-4-methoxy benzoicacid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,XKPMZMJYQDNWDG-UHFFFAOYSA Use and application,Benzoic acid, 3-bromo-5-hydroxy-4-methoxy- technical grade,usp/ep/jp grade.


Related News: Bulk bulk medicines: overcapacity, low prices, future capacity and output will be reduced, and it is possible to transfer foreign production. 3-Bromo-5-hydroxy-4-methoxybenzoic acid manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 3-Bromo-5-hydroxy-4-methoxybenzoic acid supplier The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study. 3-Bromo-5-hydroxy-4-methoxybenzoic acid vendor If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. 3-Bromo-5-hydroxy-4-methoxybenzoic acid factory China is now dealing with another disease outbreak �� this one mostly affecting animals but also potentially deadly among people.